DGAP-News: Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose
|
DGAP-News: Marinomed Biotech AG
/ Key word(s): Quarter Results
Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose 23.05.2022 / 07:45 The issuer is solely responsible for the content of this... |